查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433415

全球支氣管活體組織切片設備市場 2023-2030

Global Bronchial Biopsy Devices Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 100 Pages | 商品交期: 2-3個工作天內

價格

預計全球支氣管活體組織切片設備市場在預測期內將以 7.4%的CAGR成長。關鍵因素包括肺癌、慢性阻塞性肺病（COPD）等呼吸系統疾病的流行，老年人口的增加以及推動市場成長的微創手術需求的增加。據肺癌研究基金會表示，到2023年，美國估計將有 238,340 人被診斷出患有肺癌。每 16 個人中就有 1 人患有肺癌，其中每 16 名男性中就有 1 名患有肺癌，每 17 名女性中就有 1 名患有肺癌。此外，人口老化更容易患呼吸道疾病，這增加了對支氣管活體組織切片等診斷程序的需求，以解決這些健康問題。2022年11月，《老年人口統計：美國老化肖像》一文報道表示，美國有5,410萬成年人，即16.3%的老年人是老年人，其中包括65歲或以上的老年人。預計到2040年，老年人口將增至 22.0%，到2060年將增至 25.0%。

細分市場前景

全球支氣管活體組織切片設備市場依產品和最終用戶進行細分。根據產品，市場細分為活體組織切片鉗、經支氣管針吸（Tbna）針和細胞刷。此外，根據最終用戶，市場細分為醫院、診斷成像中心、研究和學術機構等。其他包括乳房護理中心。在最終用戶中，由於設施先進、交通便利、交通和住房援助，醫院細分市場預計將佔據相當大的市場佔有率。

經支氣管針抽吸（Tbna）針子細分市場預計將在全球支氣管活體組織切片設備市場中佔據相當大的佔有率

其中，由於全球肺癌盛行率不斷上升，加上對準確、具成本效益和微創診斷程序的需求，增加了對 TBNA 設備的需求，TBNA針子細分市場預計將在全球支氣管活體組織切片設備市場中佔據相當大的佔有率。據美國國立衛生研究院（NIH）表示，在過去的十年中，支氣管內超音波引導下的 TBNA（EBUS-TBNA）已成為評估未確診胸內淋巴結腫大的首選診斷程序。 EBUS-TBNA是目前肺癌縱膈分期的首選方法。根據發表的題為「支氣管內超音波引導經支氣管針抽吸：技術與挑戰」的文章 ，在印度各地的669 名呼吸科醫生中，只有27.0%的印度受訪呼吸科醫生進行了EBUS-TBNA，而74%的人使用了傳統的TBNA。這些因素迫使主要參與者推出產品來滿足市場上產品的需求。2023年 9月，Broncus Medical 推出了用於微創診斷應用的新型 BioStar 經支氣管抽吸針（TBNA）。它設計用於傳統 TBNA（cTBNA）和 EBUS-TBNA 診斷技術。該公司提供 21G、22G 和 25G 配置的針。

區域展望

全球支氣管活體組織切片設備市場根據地理位置進一步細分，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，由於肺癌盛行率不斷上升，政府措施和醫療保健政策具有凝聚力，新興經濟體醫療保健基礎設施的改善推動支氣管活體組織切片設備市場，預計亞太地區將在全球市場中佔據顯著佔有率在亞太地區。

北美地區預計全球支氣管活體組織切片設備市場將以顯著的CAGR成長

在所有地區中，北美地區預計在預測期內將以相當大的CAGR成長。由於醫療保健產業發達，加上呼吸道疾病盛行率不斷上升，北美市場不斷成長。此外，意識的提高、對創新支氣管活體組織切片設備的需求不斷增加以及醫療保健支出的增加預計將在預測期內推動市場成長。根據經濟合作暨發展組織（OECD）的資料，2021年，美國醫療保健支出佔國內生產毛額（GDP）的17.8%，幾乎是經合組織國家平均水準的兩倍。此外，根據醫療保險和醫療補助服務中心（CMMS）2022年 3月發布的資料，報告發現，2021-2030年國家醫療支出年均成長預計為 5.1%，達到近 6.8 兆美元至2030年。同期國家GDP 預計每年成長5.1%。根據可比較的預測成長率，預計2030年衛生保健佔 GDP 的比重將為 19.6%，與2020年 19.7%的比重幾乎相同。因此，該國不斷成長的醫療支出預計將增加公司活動和政府在開發高效能支氣管活體組織切片設備方面的舉措，推動市場成長。

市場參與者展望

服務於支氣管活體組織切片設備市場的主要公司包括 Becton、Dickinson, and Co.、Cook Medical Inc.、CONMED Corp.、Medtronic plc 等。市場參與者透過各種策略（包括併購、夥伴關係、合作、融資和新產品發布），為市場成長做出了巨大貢獻，以保持市場競爭力。例如，2023年 5月，Menarini Silicon Biosystems 與 Alivio Health 合作，擴大患者獲得 CELLSEARCH（R）液體活體組織切片測試的機會。該協議允許 Alivio Health 的客戶和提供者優先獲得 CELLSEARCH CTC 測試，促進不同疾病階段的癌症患者的縱向監測。

報告涵蓋：

  • 2023年市場價值資料分析及2031年預測。
  • 每個細分市場的年化市場收入（百萬美元）。
  • 主要地理區域的國家分析。
  • 在全球支氣管活體組織切片設備市場營運的主要公司。根據現有資料，報告中還提供了與新產品發布相關的資訊以及相關新聞。
  • 透過確定未來強勁成長的關鍵細分市場來分析業務策略。
  • 市場進入和市場擴張策略分析。
  • 透過識別市場中「誰的立場」來制定競爭策略。

目錄

第1章 報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 依細分
    • 依地區

第2章 市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第3章 競爭格局

  • 主要公司分析
  • Becton, Dickinson, and Co.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Cook Medical Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • CONMED Corp.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Medtronic plc
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第4章 市場細分

  • 全球支氣管活體組織切片設備市場（依產品）
    • 切片鉗
    • 經支氣管針吸抽吸（Tbna）針
    • 細胞學刷
    • 液體切片儀器
  • 全球支氣管活體組織切片設備市場（依最終用途）
    • 醫院
    • 診斷影像中心
    • 研究和學術機構
    • 其他（乳房護理中心）

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第6章 公司簡介

  • Argon Medical Devices Inc.
  • B. Braun Medical Inc.
  • Boston Scientific Corp.
  • Cardinal Health, Inc.
  • F. Hoffmann-La Roche AG
  • Fujifilm Corp.
  • Hobbs Medical Inc.
  • Hologic, Inc.
  • Horizons International Corp.
  • INRAD Inc.
  • NeoGenomics Laboratories, Inc
  • Olympus Corp.
  • QIAGEN, Inc.
  • Stryker Corp.
  • Telemed Systems, Inc.
Product Code: OMR2028066

Global Bronchial Biopsy Devices Market Size, Share & Trends Analysis Report by Product (Biopsy Forceps, Transbronchial Needle Aspiration (Tbna) Needles, and Cytology Brushes), and by End-Use (Hospitals, Diagnostic Imaging Centers, Research and Academic Institutes, and Others), Forecast Period (2024-2031)

The global bronchial biopsy devices market is anticipated to grow at a CAGR of 7.4% during the forecast period. Pivotal factors include prevalence of respiratory diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), rising geriatric population, and increasing demand for minimally invasive procedures driving the market growth. According to the Lung Cancer Research Foundation, in 2023, an estimated 238,340 people will be diagnosed with lung cancer in the US. Lung cancer affected 1 in 16 persons in their lifetime 1 in 16 males and 1 in 17 women. Further, the ageing population is more inclined to respiratory diseases, which increases the demand for diagnostic procedures such as bronchial biopsies to address these health issues. In November 2022, the article "Senior Population Statistics: A Portrait of Aging Americans", reported 54.1 million adults or 16.3% of the US population are seniors including aged 65 or older. The senior population is expected to rise to 22.0% by 2040 and 25.0% by 2060.

Segmental Outlook

The global Bronchial Biopsy Devices market is segmented on the product, and end user. Based on the product, the market is sub-segmented into biopsy forceps, transbronchial needle aspiration (Tbna) needles, and cytology brushes. Further, based on end user, the market is sub-segmented into hospitals, diagnostic imaging centers, research and academic institutes, and others. Other includes breast care centers. Among the end users, the hospitals sub-segment is anticipated to hold a considerable share of the market, owing to the advance facilities, easily accessible, transportation and housing assistance.

The Transbronchial Needle Aspiration (Tbna) Needles Sub-Segment is Anticipated to Hold a Considerable Share of the Global Bronchial Biopsy Devices Market

Among the product, the TBNA needles sub-segment is expected to hold a considerable share of the global bronchial biopsy devices market, owing to the rising prevalence of lung cancer globally, coupled with the demand for accurate, cost-effective, and minimally invasive diagnostic procedures, contributing to the demand for TBNA devices. According to the National Institutes of Health (NIH), over the past decade, endobronchial ultrasound-guided TBNA (EBUS-TBNA) has become the preferred diagnostic procedure for evaluating undiagnosed intrathoracic lymphadenopathy. EBUS-TBNA is currently the preferred method for mediastinal staging of lung cancer. As per the published article titled "Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: Techniques and Challenges," among 669 respiratory physicians throughout India, only 27.0% of surveyed respiratory physicians in India performed EBUS-TBNA, while 74% used conventional TBNA. Such factors compelled the key players to launch product to carer the demand of the product in the market. In September 2023, Broncus Medical introduced the new BioStar Transbronchial Aspiration Needle (TBNA) for minimally invasive diagnostic applications. It has been designed to be used for both conventional TBNA (cTBNA) and EBUS-TBNA diagnostic techniques. The company offers the needle in 21G, 22G and 25G configurations.

Regional Outlook

The global bronchial biopsy devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the rising prevalence of lung cancer, cohesive government initiatives and healthcare policies, improving healthcare infrastructure in emerging economies are driving the bronchial biopsy devices market in the Asia-Pacific.

The North America Region is Expected to Grow at a Significant CAGR in the Global Bronchial Biopsy Devices Market

Among all regions, North America region is anticipated to grow at a considerable CAGR over the forecast period. The North America market is growing owing to the presence of a well-developed healthcare sector, along with the rising prevalence of prevalence of respiratory diseases. Additionally, rising awareness, increasing demand for innovative bronchial biopsy devices, and rising healthcare expenditure are projected to drive market growth during the forecast period. According to the Organization for Economic Co-operation and Development (OECD), in 2021, the US spent 17.8% of gross domestic product (GDP) on healthcare, nearly twice as much as the average OECD country. Additionally, as per the data published by the Centers for Medicare & Medicaid Services (CMMS), in March 2022, the report found that annual growth in national health spending is projected to average 5.1% over 2021-2030, and to reach nearly $6.8 trillion by 2030. Growth in the nation's GDP is also anticipated to be 5.1% annually over the same period. As a result of the comparable projected rates of growth, the health share of GDP is expected to be 19.6% in 2030, nearly the same as the 2020 share of 19.7%. Thus, the growing health spending in the country is estimated to increase company activities and government initiatives in developing efficient bronchial biopsy devices, thus pushing the market growth.

Market Players Outlook

The major companies serving the bronchial biopsy devices market include Becton, Dickinson, and Co., Cook Medical Inc., CONMED Corp., Medtronic plc, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2023, Menarini Silicon Biosystems partnered with Alivio Health to expand patient access to CELLSEARCH® liquid biopsy tests. The agreement allowed Alivio Health clients and providers preferred access to CELLSEARCH CTC tests, facilitating longitudinal monitoring of cancer patients at different disease stages.

The Report Covers:

  • Market value data analysis of 2023 and forecast to 2031.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global bronchial biopsy devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Becton, Dickinson, and Co.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Cook Medical Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. CONMED Corp.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Medtronic plc
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Bronchial Biopsy Devices Market by Product
    • 4.1.1. Biopsy Forceps
    • 4.1.2. Transbronchial Needle Aspiration (Tbna) Needles
    • 4.1.3. Cytology Brushes
    • 4.1.4. Liquid Biopsy Instruments
  • 4.2. Global Bronchial Biopsy Devices Market by End-Use
    • 4.2.1. Hospitals
    • 4.2.2. Diagnostic Imaging Centers
    • 4.2.3. Research and Academic Institutes
    • 4.2.4. Others (Breast Care Centers)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Argon Medical Devices Inc.
  • 6.2. B. Braun Medical Inc.
  • 6.3. Boston Scientific Corp.
  • 6.4. Cardinal Health, Inc.
  • 6.5. F. Hoffmann-La Roche AG
  • 6.6. Fujifilm Corp.
  • 6.7. Hobbs Medical Inc.
  • 6.8. Hologic, Inc.
  • 6.9. Horizons International Corp.
  • 6.10. INRAD Inc.
  • 6.11. NeoGenomics Laboratories, Inc
  • 6.12. Olympus Corp.
  • 6.13. QIAGEN, Inc.
  • 6.14. Stryker Corp.
  • 6.15. Telemed Systems, Inc.

LIST OF TABLES

  • 1. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
  • 2. GLOBAL BIOPSY FORCEPS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 3. GLOBAL TRANSBRONCHIAL NEEDLE ASPIRATION (TBNA) BRONCHIAL BIOPSY NEEDLES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 4. GLOBAL CYTOLOGY BRONCHIAL BIOPSY BRUSHES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 5. GLOBAL LIQUID BIOPSY INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 6. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023-2031 ($ MILLION)
  • 7. GLOBAL BRONCHIAL BIOPSY DEVICES FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 8. GLOBAL BRONCHIAL BIOPSY DEVICES FOR DIAGNOSTIC IMAGING CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 9. GLOBAL BRONCHIAL BIOPSY DEVICES FOR RESEARCH AND ACADEMIC INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 10. GLOBAL BRONCHIAL BIOPSY DEVICES FOR OTHER END-USE MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 11. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 12. NORTH AMERICAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 13. NORTH AMERICAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
  • 14. NORTH AMERICAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023-2031 ($ MILLION)
  • 15. EUROPEAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 16. EUROPEAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
  • 17. EUROPEAN BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023-2031 ($ MILLION)
  • 18. ASIA-PACIFIC BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 19. ASIA-PACIFIC BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
  • 20. ASIA-PACIFIC BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023-2031 ($ MILLION)
  • 21. REST OF THE WORLD BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 22. REST OF THE WORLD BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
  • 23. REST OF THE WORLD BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023-2031 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023 VS 2031 (%)
  • 2. GLOBAL BIOPSY FORCEPS MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 3. GLOBAL TRANSBRONCHIAL NEEDLE ASPIRATION (TBNA) BRONCHIAL BIOPSY NEEDLES MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 4. GLOBAL CYTOLOGY BRONCHIAL BIOPSY BRUSHES MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 5. GLOBAL LIQUID BIOPSY INSTRUMENTS MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 6. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2023 VS 2031 (%)
  • 7. GLOBAL BRONCHIAL BIOPSY DEVICES FOR HOSPITALS MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 8. GLOBAL BRONCHIAL BIOPSY DEVICES FOR DIAGNOSTIC IMAGING CENTERS MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 9. GLOBAL BRONCHIAL BIOPSY DEVICES FOR RESEARCH AND ACADEMIC INSTITUTES MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 10. GLOBAL BRONCHIAL BIOPSY DEVICES FOR OTHER END-USE MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 11. GLOBAL BRONCHIAL BIOPSY DEVICES MARKET SHARE BY REGION, 2023 VS 2031 (%)
  • 12. US BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 13. CANADA BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 14. UK BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 15. FRANCE BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 16. GERMANY BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 17. ITALY BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 18. SPAIN BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 19. REST OF EUROPE BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 20. INDIA BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 21. CHINA BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 22. JAPAN BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 23. SOUTH KOREA BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 24. REST OF ASIA-PACIFIC BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 25. REST OF THE WORLD BRONCHIAL BIOPSY DEVICES MARKET SIZE, 2023-2031 ($ MILLION)